Latest AI Startup Funding Rounds
Funding for companies building AI models, tools and applications. Explore the products, customers and businesses attracting capital.
- Rounds
- 772 Jul 30 – Oct 27, 2026
- Disclosed funding
- $99.5B 570 disclosed amounts
- Median round
- $12M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| D DiscreteStackCompany profile DiscreteStack packages open-weight AI models into self-hosted systems for enterprises that need control over their infrastructure and data. DiscreteStack packages open-weight AI models into self-hosted systems for enterprises that need control over their infrastructure and data. | €800K | Seed | AI | Bulgaria | Investors | |
| I ImmolyCompany profile Immoly provides AI-assisted property-management software for landlords and smaller property managers to organize tenant communication, repairs and documents. Immoly provides AI-assisted property-management software for landlords and smaller property managers to organize tenant communication, repairs and documents. | Undisclosed | Strategic investmentUndisclosed | AI, Proptech | Germany | Investors | |
| T TrajectoryCompany profile A continual-learning platform that post-trains enterprise AI models using real product usage data. A continual-learning platform that post-trains enterprise AI models using real product usage data. | $40M | Series A | AI | — | Investors | |
| D Databricks provides a cloud data warehouse and AI software products. | $5B | Growth | AI | United States | Investors | |
 LovableCompany profile Lovable helps people build software by describing what they want to an AI development platform. Lovable helps people build software by describing what they want to an AI development platform. | $400M | Series CSeries C+ | AI | Sweden | Investors | |
| BT Beyang TherapeuticsCompany profile AI-driven drug discovery company using its ExCEED molecular design platform AI-driven drug discovery company using its ExCEED molecular design platform | $30M | Series A | AI, Biotech | China | Investors | |
| R RemepyCompany profile Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps | $36M | Series A | AI, Biotech | Israel | Investors | |
| C ClearJetCompany profile Connects shippers to unused commercial flight cargo space for faster package delivery Connects shippers to unused commercial flight cargo space for faster package delivery | $25M | Growth | AI, Logistics | United States | Investors | |
 BlacksmithCompany profile Cloud infrastructure for building and testing software through continuous integration workflows. Cloud infrastructure for building and testing software through continuous integration workflows. | $45M | Series B | AI, Developer tools | United States | Investors | |
| SA Skan AICompany profile Builds a context graph of enterprise work to ground AI agents in real workflows Builds a context graph of enterprise work to ground AI agents in real workflows | $63M | Series CSeries C+ | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 30, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Databuddy Analytics
27rounds2led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
26rounds12led - 3NVIDIA
Bedrock Robotics, Foresight, Hiverge
19rounds0led - 4General Catalyst
Provision Labs, Tractian, Legora
18rounds5led - 5Sequoia Capital
Nevis, TypeSafe AI, Healthleap
17rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.